Novo cuts Wegovy prices in some Chinese provinces, local media reports

Core Viewpoint - Danish drugmaker Novo Nordisk has significantly reduced the prices of its obesity drug Wegovy in certain provinces of China, nearly halving the costs [1] Company Summary - Novo Nordisk has implemented a price reduction strategy for Wegovy, targeting specific regions in China to enhance accessibility [1]